- The Bank of England hints at a possible additional interest rate hike, with a higher threshold for further policy tightening.
- BUZZ - A sweeping Democratic victory casts a shadow over AI expansion prospects, causing US chip stocks to tumble
- Updated: Wendy's rejected the $1.4 billion acquisition offer led by Trian
- Appian Q3 net income jumps 58% to $12.34 million; Q3 revenue rises 25% to $234.63 million
- Certara Q3 net income attributable to common stockholders more than triples to $5.59 million year over year
- Malibu Boats swings to net income of $6.11 million for three months ended Sept. 30, 2026
- MNTN, INC. <MNTN.N>: NEEDHAM CUTS TARGET PRICE TO $8 FROM $18
- Acacia Research Q3 2026 net loss more than doubles year over year to $5.56 million
- Vistance Networks CEO Chuck Treadway Steps Down Feb. 1, 2027
- Insight Molecular Diagnostics to Report Third-Quarter Financial Results
- AMCOR PLC : DEUTSCHE BANK CUTS TARGET PRICE TO $45 FROM $50
- AMCOR PLC : DEUTSCHE BANK CUTS TARGET PRICE TO $45 FROM $50
- AMCOR PLC : DEUTSCHE BANK CUTS TARGET PRICE TO $45 FROM $50
- AMCOR PLC : DEUTSCHE BANK CUTS TARGET PRICE TO $45 FROM $50
- AMCOR PLC : DEUTSCHE BANK CUTS TARGET PRICE TO $45 FROM $50
- AMCOR PLC : DEUTSCHE BANK CUTS TARGET PRICE TO $45 FROM $50
- Charming Medical Faces Nasdaq Trading Suspension Nov. 9 Unless It Appeals
- Fate Therapeutics Q3 2026 net loss narrows year over year to $30.69 million
- Graycliff Exploration reports high-grade gold in five new drill holes at Shakespeare project
- TABOOLA.COM LTD <TBLA.O>: STONEX CUTS TO HOLD FROM BUY
- Astec Industries Q3 net loss more than doubles year over year to $12.2 million
- Cartier Silver reports highest-grade drill intercept to date at Bolivia’s Gonalbert project
- CYTOKINETICS, INCORPORATED <CYTK.O>: CITIGROUP RAISES TARGET PRICE TO $105 FROM $99
- Lexicon Pharmaceuticals Q3 2026 net loss widens 9% to $14 million
- Wendy's third-quarter net income drops 66% to $15.1 million
- ANDERSONS INC : STONEX RAISES TARGET PRICE TO $100 FROM $90
- Illumin Q3 net loss narrows 15% year-over-year to CAD 1.82 million
- ZILLOW GROUP, INC. <ZG.O>: STONEX CUTS TARGET PRICE TO $70 FROM $80
- HUT 8 CORP <HUT.O>: STONEX CUTS TARGET PRICE TO $165 FROM $195
- WAYFAIR INC. <W.N>: WEDBUSH RAISES TARGET PRICE TO $138 FROM $125
- Evergy Q3 2026 adjusted EPS rises 27% year over year to $2.58
- Tecnoglass Q3 Net Income Falls 52% Year Over Year to $22.75 Million
- Lightning Resource Grants 1,800,000 Deferred Share Units to Directors
- Akebia’s Thrice-Weekly Vadadustat Meets Primary Endpoint in VOCAL Anemia Trial
- Charming Medical Receives Nasdaq Delisting Notice, Faces Nov. 5 Appeal Deadline
- Allegiance Resources Acquires Three British Columbia Tungsten Projects
- Envoy Medical Q3 net loss narrows 39% to $3.93 million
- Lightspeed Commerce: Saw 2Q 17% Rev Growth in Retail in N Amer and Hospitality in Europe >LSPD.T
- Korsana Biosciences 3Q Loss/Shr $3.19 >KRSA
- Korsana Biosciences 3Q Loss $46.4M >KRSA
- Climb Bio 3Q Loss/Shr 18c >CLYM
- Wendy's: Anticipate Our Decision on the Breakfast Daypart Could Unlock Up to $200 M in Restaurant-Level EBITDA Across the System >WEN
- Climb Bio 3Q Loss $14.6M >CLYM
- Lincoln International 3Q Adj EPS 46c >LCLN
- Verisk Analytics 3Q Rev $809M >VRSK
- Verisk Analytics 3Q Net $219.2M >VRSK
- Verisk Analytics Sees FY Rev $3.19B-$3.24B >VRSK
- Verisk Analytics 3Q Adj EPS $1.96 >VRSK
- Verisk Analytics Sees FY Adj EPS $7.45-Adj EPS $7.75 >VRSK
- Verisk Analytics 3Q EPS $1.70 >VRSK
- Real REMAX Group 3Q Rev $727.9M >REAX
- Monte Rosa Therapeutics swings to Q3 net income of $3.06 million from year-earlier loss
- SCHRODINGER INC <SDGR.O>: BMO RAISES TARGET PRICE TO $35 FROM $30
- WW International Q3 net income swings to $15.1 million profit year-over-year
- Middleby Q3 2026 adjusted EBITDA rises 10% to $155.8 million
- Obsidian Energy Q3 2026 net income rises 7% to CAD 18 million
- WARRIOR MET COAL INC <HCC.N>: BMO CUTS TARGET PRICE TO $95 FROM $100
- INTERNATIONAL FLAVORS & FRAGRANCES INC. <IFF.N>: CITIGROUP RAISES TARGET PRICE TO $105 FROM $100
- Frontdoor Raises 2026 Adjusted EBITDA Outlook to $590 Million-$600 Million
- Lincoln International 3Q EPS 25c >LCLN
- Lightspeed Commerce 2Q Rev $323.8M >LSPD.T
- Shift4 Payments 3Q Adj EPS $1.49 >FOUR
- Wendy's: With ABout $413 M in Cash and $174 M of Free Cash Flow Yr-to-date, Well Positioned to Invest in Our Dave's Way Strategy >WEN
- Illumin Holdings 3Q Loss/Shr C$0.03 >ILLM.T
- Labrador Gold Board Launches Strategic Review to Maximize Shareholder Value
- BKV Q3 2026 net income attributable to shareholders drops 65% year over year to $29.43 million
- Wendy's independent committee rejects Trian-led group's $7.35-per-share offer
- ROYALTY PHARMA <RPRX.O>: CITIGROUP RAISES TARGET PRICE TO $78 FROM $70
- American Pacific Mining Intersects Gold Beyond Historic Workings at Madison Project
- Kimbell Royalty Partners Q3 net income falls 23% year over year to $17.25 million
- ELEMENT FLEET MANAGEMENT CORP. <EFN.TO>: BMO CUTS TARGET PRICE TO C$24 FROM C$38
- GLOBALFOUNDRIES INC. <GFS.O>: WEDBUSH CUTS TARGET PRICE TO $45 FROM $72
- Malibu Boats 1Q EPS 30c >MBUU
- Shift4 Payments 3Q Rev $1.32B >FOUR
- Keel Infrastructure 3Q Cont Ops Loss/Shr 10c >KEEL.T
- First Majestic Silver Q3 2026 net earnings more than double year over year to USD 74.5 million
- FAIRFAX FINANCIAL HOLDINGS LIMITED <FFH.TO>: BMO RAISES TARGET PRICE TO C$2850 FROM C$2700
- Visa forecasts US holiday retail sales to rise 4.5% in 2026
- LCI Industries Q3 Net Income Falls 20% to $50.09 Million
- EMERSON <EMR.N>: CITIGROUP RAISES TARGET PRICE TO $198 FROM $182
- Iovance Biotherapeutics Q3 net loss narrows 76% year over year to $22.27 million
- --Earnings Flash (FOUR) Shift4 Payments Posts Q3 Adjusted EPS $1.49, vs. FactSet Est of $1.36
- -- Earnings Flash (MH) McGraw Hill, Inc. Posts Q2 Adjusted EPS $0.75 per Share, vs. FactSet Est of $0.72
- Paramount Resources Q3 Net Loss Widens YoY
- -- Earnings Flash (TIC) TiC Solutions, Inc. Reports Q3 Revenue $639.6M, vs. FactSet Est of $615.0M
- Market Chatter: Goldman Sachs, Apollo Begin Marketing $40 Billion SpaceX Chip Financing Deal
- -- Earnings Flash (MAIR) Madison Air Solutions Corporation Posts Q3 Adjusted EPS $0.38 per Share
- -- Earnings Flash (MAIR) Madison Air Solutions Corporation Reports Q3 Revenue $1.13B, vs. FactSet Est of $1.06B
- Rockwell Automation's Fiscal Q4 Adjusted Earnings, Sales Increase; Fiscal 2027 Outlook Issued
- -- Earnings Flash (GPGI) GPGI, Inc. Reports Q3 Revenue $509.6M
- TD Cowen Downgrades Enerflex to Hold From Buy
- -- Earnings Flash (TINY.TO) Tiny Reports Q3 Revenue CA$52.3M
- --GUIDANCE: (IOVA) Iovance Biotherapeutics Expects 2026 Product Revenue Range $410M to $420M
- --Earnings Flash (AMLX) Amylyx Pharmaceuticals Posts Q3 Loss $0.38 a Share, vs. FactSet Est of $0.37 Loss
- Tapestry Fiscal Q1 Non-GAAP Earnings, Net Sales Rise; Fiscal 2027 Outlook Raised -- Shares Up Pre-Bell
- --Earnings Flash (IOVA) Iovance Biotherapeutics Posts Q3 Loss $0.05 a Share, vs. FactSet Est. of $0.08 Loss
- -- Earnings Flash (VRSK) Verisk Analytics, Inc. Posts Q3 Adjusted EPS $1.96 per Share, vs. FactSet Est of $1.92
- -- Earnings Flash (ACB.TO) Aurora Cannabis Reports Q2 Revenue CA$86.0M, vs. FactSet Est of CA$71.4M
- -- Earnings Flash (GPGI) GPGI, Inc. Posts Q3 Adjusted EPS $0.26 per Share, vs. FactSet Est of $0.25
- -- Earnings Flash (VRSK) Verisk Analytics, Inc. Reports Q3 Revenue $809.0M, vs. FactSet Est of $805.9M
